J. Prieto

J. Prieto, B. Sangro, J. Quiroga, 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membrane

J. Prieto, N. Abrescia, C. Smerdou, 2016, Cellular and Molecular Life Sciences.

Regulation of stathmin phosphorylation in mouse liver progenitor‐29 cells during proteasome inhibition

J. Prieto, M. I. Mora, F. Corrales, 2009, Proteomics.

[Insulin-like growth factor I (IGF-I) and liver cirrhosis].

J. Prieto, J. Quiroga, M. Conchillo, 2007, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Cardiotrophin-1 Promotes a High Survival Rate in Rabbits with Lethal Fulminant Hepatitis of Viral Origin

J. Prieto, J. González‐Gallego, Irene Crespo, 2011, Journal of Virology.

A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen

J. Prieto, V. Schmitz, L. Wang, 2002, Gene Therapy.

Early predictors of response to treatment in patients with chronic hepatitis C.

J. Prieto, M. Civeira, J. Prieto, 1999, Journal of hepatology.

Inhibitor of TGF-Regulatory T Cell Activity with a Peptide In Vitro and In Vivo Down-Regulation of Borrás

J. Prieto, S. V. Deventer, J. Lasarte, 2008 .

Transmission of hepatitis C virus infection to tree shrews.

J. Prieto, J. Lasarte, J. Riezu-Boj, 1998, Virology.

The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection

D. Lavillette, B. Bartosch, F. Cosset, 2009, Journal of Virology.

Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.

A. Ribas, H. Lassmann, J. Prieto, 2005, Cancer research.

Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus.

Lieping Chen, J. Prieto, I. Melero, 2005, Vaccine.

Helper cell-independent antitumor activity of potent CD8+ T cell epitope peptide vaccines is dependent upon CD40L

J. Prieto, E. Huarte, J. Lasarte, 2013, Oncoimmunology.

Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis.

J. Prieto, C. Leclerc, J. Lasarte, 2010, Vaccine.

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides.

J. Prieto, J. Lasarte, P. Sarobe, 1999, International immunology.

Abnormal Priming of CD 4 T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E 1 Proteins

J. Prieto, J. Lasarte, P. Sarobe, 2002 .

Gene therapy of liver cancer.

J. Prieto, B. Sangro, R. Hernández-Alcoceba, 2006, Annals of hepatology.

Gene therapy of liver cancer.

J. Prieto, B. Sangro, R. Hernández-Alcoceba, 2006, World journal of gastroenterology.

Gene therapy of neoplastic liver diseases.

J. Prieto, B. Sangro, M. Herraiz, 2003, The international journal of biochemistry & cell biology.

N-Acetyl Cysteine Enhances the Response to Interferon-α in Chronic Hepatitis C: A Pilot Study

J. Prieto, M. Civeira, N. García, 1993 .

Glutathione depletion in chronic hepatitis C

J. Prieto, N. García, O. Beloqui, 1993 .

Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.

J. Prieto, C. Qian, S. Kochanek, 2006, Cancer research.

Liver transplantation in cirrhotic patients with diabetes mellitus: Midterm results, survival, and adverse events

J. Prieto, B. Sangro, J. Quiroga, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis.

J. Prieto, J. Quiroga, I. Castilla-Cortázar, 1997, Journal of hepatology.

Improving efficacy of interleukin‐12‐transfected dendritic cells injected into murine colon cancer with anti‐CD137 monoclonal antibodies and alloantigens

Lieping Chen, J. Prieto, C. Qian, 2004, International journal of cancer.

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.

J. Prieto, N. Fausto, A. Castilla, 1991, The New England journal of medicine.

Hepatic differentiation of mouse iPS cells and analysis of liver engraftment potential of multistage iPS progeny

J. Prieto, R. Aldabe, L. Guembe, 2013, Journal of Physiology and Biochemistry.

Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8

J. Prieto, B. Sangro, I. Melero, 2005, International journal of cancer.

Cells as vehicles for therapeutic genes to treat liver diseases

J. Prieto, C. Qian, P. Sarobe, 2008, Gene Therapy.

Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion

André M. N. Silva, J. Prieto, P. Paulo, 2021, bioRxiv.

Effects of IFN‐α as a signal‐3 cytokine on human naïve and antigen‐experienced CD8+ T cells

J. Prieto, I. Melero, S. Hervás-Stubbs, 2010, European journal of immunology.

Fatty Liver Disease and Nutritional Liver Damage

J. Prieto, J. Zozaya, F. Conchillo, 1992 .

Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12

J. Prieto, C. Qian, Xiaoming Xie, 1999, Cancer Gene Therapy.

Identification of replication-competent HSV-1 Cgal+ strain targets in a mouse model of human hepatocarcinoma xenograft.

J. Prieto, A. Epstein, M. I. Mora, 2009, Journal of proteomics.

Requires Efficient Long-Term Immune Semliki Forest Virus Expressing IL-12 Eradication of Liver-Implanted Tumors by Hervas

J. Prieto, P. Berraondo, E. Casales, 2013 .

Eradication of Liver-Implanted Tumors by Semliki Forest Virus Expressing IL-12 Requires Efficient Long-Term Immune Responses

J. Prieto, P. Berraondo, S. Hervás-Stubbs, 2013, The Journal of Immunology.

Evaluation of monocytes as carriers for armed oncolytic adenoviruses in murine and Syrian hamster models of cancer.

J. Prieto, C. Ortiz-de-Solórzano, M. Buñuales, 2012, Human gene therapy.

Circulating adrenomedullin in cirrhosis: relationship to hyperdynamic circulation.

J. Prieto, J. Quiroga, C. Fernández-Rodríguez, 1998, Journal of hepatology.

Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure.

J. Prieto, J. Quiroga, M. Cobos, 1989, Gastroenterology.

Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.

N. LaRusso, J. Prieto, T. Masyuk, 2015, Journal of hepatology.

Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics

J. Prieto, F. Corrales, J. Fernández-Irigoyen, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Establishment of an orthotopic tumour model for hepatocellular carcinoma and non-invasive in vivo tumour imaging by high resolution ultrasound in mice.

T. Sauerbruch, J. Prieto, C. Qian, 2004, Journal of hepatology.

New strategies to enhance gene therapy efficiency.

J. Prieto, C. Qian, B. Sangro, 2002, Gastroenterology.

Successful Colon Cancer Eradication after Chemoimmunotherapy Is Associated with Profound Phenotypic Change of Intratumoral Myeloid Cells

J. Prieto, P. Berraondo, M. Zabala, 2011, The Journal of Immunology.

Intratumoral Myeloid Cells Profound Phenotypic Change of Chemoimmunotherapy Is Associated with Successful Colon Cancer Eradication after

J. Prieto, P. Berraondo, M. Zabala, 2010 .

Myeloid Cells Profound Phenotypic Change of Intratumoral Chemoimmunotherapy Is Associated with Successful Colon Cancer Eradication after

J. Prieto, M. Zabala, J. Fioravanti, 2010 .

Semliki Forest Virus Expressing Interleukin-12 Induces Antiviral and Antitumoral Responses in Woodchucks with Chronic Viral Hepatitis and Hepatocellular Carcinoma

J. Prieto, G. González-Aseguinolaza, B. Tennant, 2009, Journal of Virology.

Treatment of Chronic Viral Hepatitis in Woodchucks by Prolonged Intrahepatic Expression of Interleukin-12

J. Prieto, S. Kochanek, G. González-Aseguinolaza, 2008, Journal of Virology.

Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.

J. Prieto, C. Qian, B. Sangro, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(-/-) mice.

P. Bosma, J. Prieto, R. O. Oude Elferink, 2013, Biochimica et biophysica acta.

NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma

Pere Roca-Cusachs, J. Prieto, B. Sangro, 2017, Oncotarget.

Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation

J. Prieto, J. Oyarzábal, P. Coffer, 2015, The Journal of Immunology.

Enhanced antiangiogenic therapy with antibody‐collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events

J. Prieto, L. Álvarez-Vallina, F. Blanco, 2006, International journal of cancer.

Suppressor T‐cell activity in chronic hepatitis B‐virus infection: Relationship with the presence of HBV‐DNA in serum

J. Prieto, M. Civeira, A. Castilla, 1989, Journal of medical virology.

Interleukins in chronic active hepatitis B. Relationship with viral markers.

J. Prieto, M. Civeira, M. Riñón, 1987, Journal of hepatology.

Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes‐associated protein–mediated activation

R. Urtasun, J. Prieto, M. Avila, 2011, Hepatology.

Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin

J. Prieto, C. Leclerc, P. Berraondo, 2012, International journal of cancer.

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.

J. Prieto, B. Sangro, E. Huarte, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.

J. Prieto, E. Huarte, J. Lasarte, 2001, Journal of hepatology.

Combination therapy with interferon‐α plus N‐acetyl cysteine for chronic hepatitis C: A placebo controlled double‐blind multicentre study

J. Prieto, J. Garson, N. García, 2000, Journal of medical virology.

Risk factors for recurrence of hepatitis C after liver transplantation.

J. Prieto, B. Sangro, J. Quiroga, 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Tumor necrosis factor α gene expression and the response to interferon in chronic hepatitis C

J. Prieto, E. Larrea, M. Civeira, 1996, Hepatology.

Prediction of sustained remission of chronic hepatitis C after a 12-month course of alfa interferon.

J. Prieto, E. de Álava, E. Larrea, 1994, Journal of hepatology.

Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia.

J. Prieto, J. Ruiz, M. Civeira, 1993, Journal of hepatology.

A pilot study of thymus extract in chronic non‐A, non‐B hepatitis

J. Prieto, M. Civeira, A. Castilla, 1989, Alimentary pharmacology & therapeutics.

A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver.

J. Prieto, M. Avila, M. Ávila, 2014, Gastroenterology.

Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.

J. Prieto, E. Huarte, J. Lasarte, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Antisense oligonucleotides and the rational design of new antitumor drugs.

J. Prieto, R. Hernández-Alcoceba, 2005, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Identification and Characterization of a T-Helper Peptide from Carcinoembryonic Antigen

J. Prieto, J. Lasarte, E. Celis, 2004, Clinical Cancer Research.

Lymphocytes from Carcinoembryonic Antigen Identification of an Antigenic Epitope for Helper T Updated Version

J. Prieto, B. Sangro, E. Huarte, 2002 .

Disturbed Synthesis of Insulinlike Growth Factor I and Its Binding Proteins May Influence Renal Function Changes in Liver Cirrhosis

J. Prieto, J. Quiroga, C. Fernández-Rodríguez, 2001, Digestive Diseases and Sciences.

Serum angiotensin converting enzyme and C4 protein of complement as a combined diagnostic index in alcoholic liver disease.

J. Prieto, C. Fernández-Rodríguez, B. Sopeña, 2008, Liver.

Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages

J. Prieto, B. Sangro, J. Quiroga, 2011, Annals of Surgical Oncology.

Serum ferritin assay and iron status in chronic renal failure and haemodialysis.

J. Prieto, A. Hoffbrand, J. Moorhead, 1975, British medical journal.

[Obesity, inflammation and insulin resistance: role of gp 130 receptor ligands].

M. Moreno-Aliaga, J. Martínez, J. Prieto, 2008, Anales del sistema sanitario de Navarra.

Renal prostacyclin influences renal function in non-azotemic cirrhotic patients treated with furosemide.

J. Prieto, J. Quiroga, P. Labarga, 1991, Journal of hepatology.

Increased synthesis of systemic prostacyclin in cirrhotic patients.

F. Guarner, J. Prieto, J. Quiroga, 1986, Gastroenterology.

Self-inactivating helper virus for the production of high-capacity adenoviral vectors

J. Prieto, G. González-Aseguinolaza, M. Buñuales, 2011, Gene Therapy.

Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses.

J. Prieto, C. Leclerc, J. Lasarte, 2012, Vaccine.

Engineered fibroblast growth factor 19 protects from acetaminophen-induced liver injury and stimulates aged liver regeneration in mice

R. Urtasun, J. Prieto, M. Avila, 2017, Cell Death and Disease.

Cardiotrophin‐1 Regulates Adipokine Production in 3T3‐L1 Adipocytes and Adipose Tissue From Obese Mice

M. Moreno-Aliaga, J. Prieto, J. A. Martínez, 2017, Journal of cellular physiology.

Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders.

J. Prieto, S. V. van Deventer, G. González-Aseguinolaza, 2009, Human gene therapy.

Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.

M. Moreno-Aliaga, J. Balsinde, J. Prieto, 2014, Journal of hepatology.

Cardiotrophin‐1 is an anti‐inflammatory cytokine and promotes IL‐4–induced M2 macrophage polarization

J. Prieto, P. Navas, M. Romero-Gómez, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Helper-dependent adenoviral liver gene therapy protects against induced attacks and corrects protein folding stress in acute intermittent porphyria mice.

J. Prieto, A. Fontanellas, R. Enríquez de Salamanca, 2013, Human molecular genetics.

MicroRNA‐506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

N. LaRusso, J. Prieto, A. Carracedo, 2018, Hepatology.

Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: Molecular mechanisms and functional implications

J. Prieto, F. Corrales, E. Santamaría, 2010, Proteomics.

Gene Therapy of Liver Tumors: Principles and Applications

J. Prieto, C. Qian, J. Ruiz, 1998, Digestion.

Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis.

J. Prieto, J. Quiroga, I. Castilla-Cortázar, 1997, Gastroenterology.

Transformed but not normal hepatocytes express UCP2

J. Prieto, M. Avila, M. Ávila, 1998, FEBS letters.

Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level.

J. Prieto, C. Qian, I. Melero, 2000, Human gene therapy.

Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats

J. Prieto, J. Quiroga, F. Ruiz, 2002, Gut.

Anchoring interferon alpha to apolipoprotein A‐I reduces hematological toxicity while enhancing immunostimulatory properties

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2011, Hepatology.

Cardiotrophin-1 is a key regulator of glucose and lipid metabolism.

M. Moreno-Aliaga, J. Martínez, B. Viollet, 2011, Cell metabolism.

Cardiotrophin-1 stimulates lipolysis through the regulation of main adipose tissue lipases[S]

M. Moreno-Aliaga, J. Martínez, J. Prieto, 2014, Journal of Lipid Research.

A Semliki Forest virus vector engineered to express IFNα induces efficient elimination of established tumors

J. Prieto, P. Berraondo, C. Smerdou, 2011, Gene Therapy.

IGF1 gene transfer into skeletal muscle using recombinant adeno-associated virus in a rat model of liver cirrhosis

J. Prieto, F. J. Novo, J. Quiroga, 2002, Journal of Physiology and Biochemistry.

Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment.

J. Prieto, J. Quiroga, I. Castilla-Cortázar, 1998, Journal of hepatology.

Biliary secretion of S‐nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat

J. Prieto, F. Corrales, J. Marin, 2010, Hepatology.

Vaccine Efficacy in Mice Regulatory T Cell Activity and Improves A Peptide Inhibitor of FOXP3 Impairs

J. Prieto, J. Lasarte, J. Riezu-Boj, 2010 .

Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells

J. Prieto, I. Melero, S. Ferrini, 2008, Gene Therapy.

Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL)

J. Prieto, C. Qian, M. Droździk, 1998, Gene Therapy.

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine‐induced liver damage

P. Boya, J. Prieto, J. Lasarte, 2003 .

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage.

P. Boya, J. Prieto, J. Lasarte, 2003, Hepatology.

Ileal FGF15 contributes to fibrosis‐associated hepatocellular carcinoma development

R. Urtasun, S. Morini, J. Prieto, 2015, International journal of cancer.

Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice

S. Morini, J. Prieto, M. Avila, 2013, Gut.

Hematotesticular barrier is altered from early stages of liver cirrhosis: effect of insulin-like growth factor 1.

J. Prieto, J. Quiroga, I. Varela-Nieto, 2004, World journal of gastroenterology.

In vitro and in vivo comparative study of chimeric liver-specific promoters.

J. Prieto, C. Qian, N. Razquin, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis.

J. Prieto, J. Quiroga, C. Fernández-Rodríguez, 1993, Gastroenterology.

Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma.

J. Prieto, M. Avila, F. Corrales, 2004, Biochimica et biophysica acta.

Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates.

J. Prieto, I. Melero, S. Hervás-Stubbs, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Characterization of high‐capacity adenovirus production by the quantitative real‐time polymerase chain reaction: a comparative study of different titration methods

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2008, The journal of gene medicine.

Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats.

J. Prieto, J. Quiroga, J. Salvador, 2001, Liver.

Biodistribution and tumor infectivity of semliki forest virus vectors in mice: effects of re-administration.

J. Prieto, C. Smerdou, J. R. Rodríguez-Madoz, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.

J. Prieto, J. Díez, M. Simón, 1991, Gastroenterology.

In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity

J. Prieto, C. Qian, V. Schmitz, 2000, Gene Therapy.

Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters

J. Prieto, M. Buñuales, R. Aldabe, 2009, Cancer Gene Therapy.

Induction of murine liver damage by overexpression of CD40 ligand provides an experimental model to study fulminant hepatic failure

T. Sauerbruch, U. Spengler, J. Prieto, 2006, Hepatology.

Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice

J. Prieto, C. Qian, V. Schmitz, 2004, Gut.

Oncostatin M Enhances the Antiviral Effects of Type I Interferon and Activates Immunostimulatory Functions in Liver Epithelial Cells

J. Prieto, V. Segura, E. Larrea, 2009, Journal of Virology.

Interplay among cardiotrophin‐1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration

J. Prieto, N. Beraza, M. Íñiguez, 2005, Hepatology.

Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12.

J. Prieto, I. Melero, P. Berraondo, 2002, Experimental Hematology.

Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.

J. Prieto, I. Melero, J. Pérez-Gracia, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity.

J. Prieto, M. Leal, J. Pineda, 1993, Journal of hepatology.

The Role of Thrombopoietin in the Thrombocytopenia of Patients with Liver Cirrhosis

J. Prieto, B. Sangro, J. Quiroga, 2005, The American Journal of Gastroenterology.

Enhanced expression of TNFα in patients with primary biliary cirrhosis

J. Prieto, E. Larrea, M. Civeira, 1994 .

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses.

J. Prieto, I. Melero, M. Buñuales, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Serum ferritin in patients with iron overload and with acute and chronic liver diseases.

S. Sherlock, J. Prieto, M. Barry, 1975, Gastroenterology.

Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

J. Prieto, E. Larrea, P. Gastaminza, 2013, Gut.

Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors.

J. Prieto, J. Lasarte, J. Riezu-Boj, 2011, Cancer research.

Monocyte‐derived dendritic cells from HCV‐infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)

J. Prieto, J. Lasarte, A. Zabaleta, 2008, Journal of viral hepatitis.

Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen‐specific cellular immune responses

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2007, Journal of medical virology.

The Extra Domain A from Fibronectin Targets Antigens to TLR4-Expressing Cells and Induces Cytotoxic T Cell Responses In Vivo1

J. Prieto, C. Leclerc, S. Hervás-Stubbs, 2007, The Journal of Immunology.

Gene therapy of cancer: induction of anti-tumor immunity.

J. Prieto, C. Qian, J. Prieto, 2004, Cellular & molecular immunology.

Identification of CD4+ and CD8+ T cell epitopes of woodchuck hepatitis virus core and surface antigens in BALB/c mice.

J. Prieto, G. González-Aseguinolaza, Á. Vales, 2010, Vaccine.

Enhanced Urinary Excretion of cGMP in Liver Cirrhosis (Relationship to Hemodynamic Changes, Neurohormonal Activation, and Urinary Sodium Excretion)

J. Prieto, J. Quiroga, C. Fernández-Rodríguez, 1997, Digestive Diseases and Sciences.

Atrial natriuretic factor in cirrhosis: relationship to renal function and hemodynamic changes.

J. Prieto, J. Quiroga, C. Fernández-Rodríguez, 1994, Journal of hepatology.

Monocyte disorder causing cellular immunodeficiency: a family study

J. Prieto, M. Civeira, M. Subirá, 1990, Clinical and experimental immunology.

Naloxone‐Reversible Monocyte Dysfunction in Patients with Chronic Fatigue Syndrome

J. Prieto, M. Subirá, A. Castilla, 1989, Scandinavian journal of immunology.

Cytoskeletal organization and functional changes in monocytes from patients with chronic hepatitis B: Relationship with viral replication

J. Prieto, M. Civeira, M. Subirá, 1989, Hepatology.

Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library.

J. Prieto, J. Lasarte, J. Riezu-Boj, 2007, Cytokine.

Proceedings: Serum ferritin in patients with iron overload and with acute and chronic liver disease.

S. Sherlock, J. Prieto, M. Barry, 1974, Gut.

Expression of interferon‐α subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferon‐α5

P. Boya, J. Prieto, E. Larrea, 2001 .

Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls

P. Boya, J. Prieto, E. Larrea, 1999, Hepatology.

Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection

J. Heeney, J. Prieto, T. Wakita, 2007, Journal of Virology.

Adjuvant interleukin-12 gene therapy for the management of colorectal liver metastases

J. Prieto, C. Qian, D. Klatzmann, 2004, Cancer Gene Therapy.

Liver Gene Transfer of Interkeukin-15 Constructs That Become Part of Circulating High Density Lipoproteins for Immunotherapy

J. Prieto, I. Melero, P. Berraondo, 2012, PloS one.

Usage of Adenovirus Expressing Thymidine Kinase Mediated Hepatocellular Damage for Enabling Mouse Liver Repopulation with Allogenic or Xenogenic Hepatocytes

J. Prieto, J. Muntané, P. Maurel, 2013, PloS one.

Ursodeoxycholic Acid Is Conjugated with Taurine to Promote Secretin-Stimulated Biliary Hydrocholeresis in the Normal Rat

J. Prieto, J. Banales, E. Sáez, 2011, PloS one.

Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger.

J. Prieto, R. Doctor, J. Banales, 2006, Hepatology.

Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein.

J. Prieto, I. Melero, P. Berraondo, 2013, Cancer research.

Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2010, Gut.

Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir therapy of hepatocellular carcinoma: The woodchuck animal model

J. Prieto, C. Qian, C. Bréchot, 2000, Cancer Gene Therapy.

Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrom

J. Prieto, B. Sangro, J. Yuste, 1996, Hepatology.

Amphiregulin: an early trigger of liver regeneration in mice.

David C. Lee, J. Prieto, M. Avila, 2005, Gastroenterology.

Role of cardiotrophin-1 in obesity and insulin resistance

M. Moreno-Aliaga, J. Prieto, D. Castaño, 2012, Adipocyte.

Cardiotrophin‐1 is an essential factor in the natural defense of the liver against apoptosis

J. Prieto, B. Holtmann, D. Pennica, 2007, Hepatology.

Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies

J. Prieto, B. Sangro, I. Melero, 2002, Gut.

Intrahepatic injection of recombinant adeno-associated virus serotype 2 overcomes gender-related differences in liver transduction.

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2006, Human gene therapy.

Leucine stimulates procollagen α1(I) translation on hepatic stellate cells through ERK and PI3K/Akt/mTOR activation

J. Prieto, M. Iraburu, M. Herraiz, 2006, Journal of cellular physiology.

The promise of gene therapy in gastrointestinal and liver diseases

J. Prieto, B. Sangro, I. Melero, 2003, Gut.

Up‐regulation of microRNA 506 leads to decreased Cl−/HCO3− anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis

N. LaRusso, J. Prieto, J. Banales, 2012, Hepatology.

Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection

J. Prieto, L. Rodrigo, C. López-Larrea, 2009, Journal of Virology.

Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.

J. Prieto, J. Lasarte, J. Riezu-Boj, 2009, Journal of hepatology.

Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria.

J. Prieto, B. Sangro, H. Petry, 2016, Journal of hepatology.

Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma.

J. Prieto, G. Mazzolini, M. Droździk, 2000, Journal of hepatology.

Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in Rats

J. Prieto, M. Enguita, J. Quiroga, 2016, PloS one.

Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice.

J. Prieto, J. Bayo, M. Enguita, 2015, Stem cells and development.

Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats

J. Prieto, I. Ojanguren, M. Martínez-Chantar, 2006, Gut.

Reactive oxygen species (ROS) mediate the effects of leucine on translation regulation and type I collagen production in hepatic stellate cells.

J. Prieto, M. Iraburu, M. J. López-Zabalza, 2007, Biochimica et biophysica acta.

Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12

J. Prieto, C. Qian, B. Sangro, 2001, Gene Therapy.

Anion exchanger 2 is essential for spermiogenesis in mice

P. Bosma, J. Prieto, C. Funk, 2003, Proceedings of the National Academy of Sciences of the United States of America.

CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b−/− mice favoring autoimmune cholangitis

J. Prieto, S. Hervás-Stubbs, R. O. Oude Elferink, 2015, Oncotarget.

Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis.

J. Prieto, J. Banales, R. O. Oude Elferink, 2008, Gastroenterology.

Cholangiocyte anion exchange and biliary bicarbonate excretion.

J. Prieto, J. Banales, J. Medina, 2006, World journal of gastroenterology.

Bicarbonate‐rich choleresis induced by secretin in normal rat is taurocholate‐dependent and involves AE2 anion exchanger

J. Prieto, R. Doctor, J. Banales, 2006 .

Defective regulation of cholangiocyte Cl−/HCO−3 and Na+/H+ exchanger activities in primary biliary cirrhosis

J. Neuberger, J. Prieto, M. Strazzabosco, 2002, Hepatology.

Assessment of biliary bicarbonate secretion in humans by positron emission tomography.

J. Martí-Climent, J. Prieto, I. Peñuelas, 1999, Gastroenterology.

Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis

J. Prieto, J. Medina, E. Martínez‐Ansó, 1997, Hepatology.

Novel Role for Amphiregulin in Protection from Liver Injury*

David C. Lee, J. Prieto, M. Avila, 2005, Journal of Biological Chemistry.

Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice

T. Sauerbruch, J. Prieto, C. Qian, 2006, Gene Therapy.

Complementary Effects of Interleukin-15 and Alpha Interferon Induce Immunity in Hepatitis B Virus Transgenic Mice

C. Ortiz de Solórzano, J. Prieto, G. González-Aseguinolaza, 2016, Journal of Virology.

Intratumoral Coinjection of Two Adenoviruses, One Encoding the Chemokine IFN-γ-Inducible Protein-10 and Another Encoding IL-12, Results in Marked Antitumoral Synergy1

J. Prieto, C. Qian, I. Melero, 2000, The Journal of Immunology.

Antitumoral Synergy Encoding IL-12 , Results in Marked-Inducible Protein-10 and Another γ IFN-Adenoviruses , One Encoding the Chemokine Intratumoral Coinjection of Two Melero

J. Prieto, C. Qian, I. Melero, 2000 .

The GCGGAA gene-regulatory motif of herpes simplex virus type-1 is also found in hepatitis C virus.

J. Prieto, M. García-Delgado, J. Vizmanos, 1995, Gene.

Anticardiolipin antibodies in chronic viral hepatitis. Do they have clinical consequences?

J. Prieto, J. Yuste, 2003, European journal of gastroenterology & hepatology.

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

J. Prieto, J. Herrero, C. Berasain, 2000, Gut.

Mediation of a Receptor Mechanism in the Uptake of Iron from Transferrin by the Hepatocyte

J. Prieto, B. Potter, R. Nunes, 1982 .

Sodium Dodecyl Sulfate / Polyacrylamide Gel Electrophoresis and Western Blotting

J. Prieto, U. Beuers, W. Kulik, 2012 .

Liver-directed gene therapy of chronic hepadnavirus infection using interferon alpha tethered to apolipoprotein A-I.

J. Prieto, B. Kallakury, G. González-Aseguinolaza, 2015, Journal of hepatology.

1120 BICARBONATE SECRETION OF MOUSE CHOLANGIOCYTES INVOLVES Na+–HCO3− COTRANSPORT IN ADDITION TO Na+-INDEPENDENT Cl−/HCO3− EXCHANGE

J. Prieto, J. Banales, R. P. Elferink, 2010 .

Bicarbonate secretion of mouse cholangiocytes involves Na+‐HCO 3− cotransport in addition to Na+‐independent Cl−/HCO3− exchange

J. Prieto, J. Banales, R. O. Oude Elferink, 2010, Hepatology.

Involvement of AE 2 anion exchanger in biliary bicarbonate excretion 3497 STUDY MODELS

J. Prieto, J. Banales, J. Medina, 2006 .

Shared apical sorting of anion exchanger isoforms AE2a, AE2b1, and AE2b2 in primary hepatocytes.

J. Prieto, I. Martinez, J. Banales, 2004, Biochemical and biophysical research communications.

Anion exchanger immunoreactivity in human salivary glands in health and Sjögren's syndrome.

J. Prieto, L. Montuenga, M. Idoate, 1995, The American journal of pathology.

Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration

R. Urtasun, F. Villarroya, J. Prieto, 2017, Gut.

The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ

J. Prieto, I. Melero, J. Pérez-Gracia, 2007, International journal of cancer.

Human Herpesvirus 6 in Spain: Seroprevalence in Blood Donors and Patients with Lymphoproliferative Disorders or HIV Infection

J. Prieto, V. Soriano, J. Tor, 1991, Vox sanguinis.

A retrospective comparative analysis of the effect of Y90-radioembolization on the survival of patients with unresectable hepatocellular carcinoma.

J. Prieto, B. Sangro, J. Quiroga, 2009, Hepato-gastroenterology.

Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells.

J. Prieto, C. Qian, B. Sangro, 2011, Journal of hepatology.

Superoxide dismutase in patients with chronic hepatitis C virus infection.

J. Prieto, M. Muñoz-Navas, E. Larrea, 1998, Free radical biology & medicine.

A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis.

J. Prieto, B. Sangro, J. García-Foncillas, 2003, Gastroenterology.

Lymphoblastoid alpha-interferon for chronic hepatitis C: a randomized controlled study.

J. Prieto, M. Civeira, A. Castilla, 1993, The American journal of gastroenterology.

Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates

J. Prieto, I. Melero, H. Petry, 2012, Journal of Translational Medicine.

αvβ3 Integrin-Mediated Adenoviral Transfer of Interleukin-12 at the Periphery of Hepatic Colon Cancer Metastases Induces VCAM-1 Expression and T-Cell Recruitment

J. Prieto, C. Qian, I. Melero, 2001 .

Opioid Peptides Modulate the Organization of Vimentin Filaments, Phagocytic Activity, and Expression of Surface Molecules in Monocytes

J. Prieto, M. Subirá, J. Arroyo, 1989, Scandinavian journal of immunology.

Gene therapy of cancer based on interleukin 12.

J. Prieto, C. Qian, B. Sangro, 2005, Current gene therapy.

Gene therapy of cancer with interleukin-12.

J. Prieto, I. Melero, G. Mazzolini, 2003, Current pharmaceutical design.

A novel polymorphism IVS2+843C>T in the alternate promoter b1 of the human AE2 anion exchanger gene

R. Urtasun, J. Prieto, S. Recalde, 2001, Human Mutation.

Promoter hypermethylation of the AE2/SLC4A2 gene in PBC

J. Prieto, A. Parés, I. Hervías, 2019, JHEP reports.

Antioxidant status aind glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C

Esther, Civeira, J. Prieto, 2001 .

Antioxidant status and glutathione metabolism in peripheral blood mononuclear cells from patients with chronic hepatitis C.

P. Boya, J. Prieto, E. Larrea, 1999, Journal of hepatology.

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas

J. Prieto, C. Qian, B. Sangro, 1999, Gene Therapy.

Different doses of adenoviral vector expressing IL-12 enhance or depress the immune response to a coadministered antigen: the role of nitric oxide.

J. Prieto, C. Qian, F. Corrales, 1999, Journal of immunology.

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

J. Prieto, I. Melero, A. Arina, 2003, Journal of Virology.

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.

J. Prieto, Á. Vales, J. Lasarte, 2002, Vaccine.

Gene therapy of liver diseases: a 2011 perspective.

J. Prieto, G. González-Aseguinolaza, J. Prieto, 2011, Clinics and research in hepatology and gastroenterology.

Tubular sodium handling in cirrhotic patients with ascites as analysed by the renal lithium clearance method

J. Prieto, J. Díez, M. Simón, 1990, European journal of clinical investigation.

Melatonin treatment reduces endoplasmic reticulum stress and modulates the unfolded protein response in rabbits with lethal fulminant hepatitis of viral origin

J. Prieto, J. González‐Gallego, B. San-Miguel, 2013, Journal of pineal research.

Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus

J. Prieto, J. González‐Gallego, Irene Crespo, 2011, Journal of pineal research.

ASIC–LIVER, PANCREAS, AND BILIARY TRACT mphiregulin: An Early Trigger of Liver Regeneration in Mice

J. Prieto, M. Ávila, J. Castillo, 2005 .

Molecular cloning and characterization of the human AE2 anion exchanger (SLC4A2) gene.

J. Prieto, J. Medina, A. Acín, 2017, Genomics.

Cytokine gene transfer into dendritic cells for cancer treatment.

J. Prieto, C. Qian, I. Melero, 2002, Current gene therapy.

Inhibitors of the lipoxygenase arachidonic acid pathway impair glycocholate efflux in isolated rat hepatocytes.

F. Guarner, J. Prieto, J. Quiroga, 1991, Journal of hepatology.

Effect of spironolactone on renal prostaglandin excretion in patients with liver cirrhosis and ascites.

F. Guarner, J. Prieto, J. Quiroga, 1986, Journal of hepatology.

Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon.

J. Prieto, J. Riezu-Boj, M. Civeira, 1993, Journal of hepatology.

Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy.

J. Prieto, C. Qian, M. Civeira, 1992, Journal of hepatology.

The Fusion Protein of IFN-α and Apolipoprotein A-I Crosses the Blood–Brain Barrier by a Saturable Transport Mechanism

Zinnia P. Parra-Guillen, J. Prieto, P. Berraondo, 2012, The Journal of Immunology.

New therapies for hepatocellular carcinoma

J. Prieto, B. Sangro, M. Ávila, 2006, Oncogene.

Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion.

J. Prieto, C. Qian, B. Sangro, 2003, Human gene therapy.

Interferon alpha bioactivity critically depends on Scavenger receptor class B type I function

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2016, Oncoimmunology.

Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance

J. Prieto, G. Missale, J. Lasarte, 2016, Journal of medical virology.

Molecular profiling of hepatocellular carcinoma in mice with a chronic deficiency of hepatic s-adenosylmethionine: relevance in human liver diseases.

Shelly C. Lu, J. Prieto, M. I. Mora, 2006, Journal of proteome research.

Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning

J. Prieto, P. Fortes, M. Ávila, 2006, The Journal of experimental medicine.

Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression.

J. Prieto, C. Qian, L. Mohr, 2008, Human gene therapy.

Melatonin modulates the autophagic response in acute liver failure induced by the rabbit hemorrhagic disease virus

J. Prieto, J. González‐Gallego, B. San-Miguel, 2014, Journal of pineal research.

Effect of sulindac on prostaglandin excretion and renal function in cirrhotic patients with ascites.

F. Guarner, J. Prieto, J. Quiroga, 1986, Scandinavian journal of gastroenterology.

Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats.

J. Prieto, J. Quiroga, I. Castilla-Cortázar, 2017, The American journal of physiology.

Effect of insulin-like growth factor I on in vivo intestinal absorption of d-galactose in cirrhotic rats.

J. Prieto, J. Quiroga, I. Castilla-Cortázar, 1999, American journal of physiology. Gastrointestinal and liver physiology.

Renal prostaglandins in cirrhosis of the liver.

F. Guarner, J. Prieto, C. Guarner, 1986, Clinical science.

Modulation of regulatory T‐cell activity in combination with interleukin‐12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B

J. Prieto, G. González-Aseguinolaza, Á. Vales, 2012, Hepatology.

Transjugular intrahepatic portal‐systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters

J. Prieto, B. Sangro, J. Quiroga, 1995, Hepatology.

Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury.

J. Prieto, M. Ávila, C. Berasain, 2008, Recent patents on cardiovascular drug discovery.

Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.

J. Prieto, R. Joplin, I. Hervías, 2008, The Journal of clinical investigation.

Gene Therapy of Hepatocellular Carcinoma

J. Prieto, C. Qian, B. Sangro, 2002, Digestive Diseases.

Lysophosphatidic acid is a potential mediator of cholestatic pruritus.

J. Prieto, K. V. van Erpecum, U. Beuers, 2010, Gastroenterology.

[The treatment of primary biliary cirrhosis with ursodeoxycholic acid. The short- and median-term results and their relation to the study of the disease].

J. Prieto, J. Quiroga, J. Zozaya, 1991, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Positron emission tomography and gene therapy: basic concepts and experimental approaches for in vivo gene expression imaging.

Iván Peñuelas, Josep M Martí-Climent, Jesús Prieto, 2004, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

De Novo neoplasia after liver transplantation: An analysis of risk factors and influence on survival

J. Prieto, B. Sangro, J. Quiroga, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection

J. Prieto, B. Sangro, J. Lasarte, 2015, Molecular therapy. Methods & clinical development.

Liver Transplant Recipients Older Than 60 Years Have Lower Survival and Higher Incidence of Malignancy

Fernando Pardo, Jesús Prieto, Bruno Sangro, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Nonmelanoma skin cancer after liver transplantation. Study of risk factors

J. Prieto, B. Sangro, J. Quiroga, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Chronic Hepatitis and Cirrhosis

J. Prieto, J. Quiroga, M. Civeira, 1992 .

The potential of gene therapy in the treatment of hepatocellular carcinoma.

J. Prieto, C. Qian, W. Caselmann, 2000, Journal of hepatology.

Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12

J. Prieto, C. Qian, B. Sangro, 2001, Hepatology.

Gene therapy of viral hepatitis and hepatocellular carcinoma

J. Prieto, C. Qian, J. Ruiz, 1999, Journal of viral hepatitis.

A blood–tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds

J. Prieto, C. Qian, M. Pajares, 2000, Gene Therapy.

A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma

B Sangro, J. Prieto, C. Qian, 2010, Cancer Gene Therapy.

Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents.

J. Prieto, D. Peng, Y. Sun, 2000, Journal of hepatology.

Ylkmsduction of hepatocellular carcinoma @ICC) using recombinant adeno-associated virus (rAA..: in vitro and in viva effwts of genotoxic agents

J. Prieto, C. Qian, M. Barajas, 2000 .

Evaluation of hepatocellular carcinoma models for preclinical studies

J. Prieto, C. Qian, R. Hernández-Alcoceba, 2005 .

Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12

J. Prieto, C. Qian, B. Sangro, 2001 .

Gene Therapy of Hepatocellular Carcinoma and Gastrointestinal Tumors

J. Prieto, C. Qian, B. Sangro, 2002, Annals of the New York Academy of Sciences.

Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease

J. Prieto, E. Baravalle, J. Prieto, 1983 .

Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.

J. Prieto, C. Qian, B. Sangro, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA

J. Prieto, D. Rowe, P. Fortes, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Future therapies for hepatocellular carcinoma.

J. Prieto, B. Sangro, Guillermo Mazzollini, 2005, European journal of gastroenterology & hepatology.

Gene therapy of liver diseases

J. Prieto, C. Qian, B. Sangro, 2004, Expert opinion on biological therapy.

Therapeutic vaccination of woodchucks against chronic woodchuck hepatitis virus infection.

J. Prieto, J. Cullen, S. Hervás-Stubbs, 1997, Journal of hepatology.

T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.

J. Prieto, J. Cullen, S. Hervás-Stubbs, 2001, Journal of Hepatology.

Overcoming class II-linked non-responsiveness to hepatitis B vaccine.

J. Prieto, C. Berasain, S. Hervás-Stubbs, 1994, Vaccine.

The woodchuck interferon‐α system: Cloning, family description, and biologic activity

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2002 .

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

J. Prieto, M. Civeira, N. García, 1993, Journal of interferon research.

Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model

J. Prieto, G. González-Aseguinolaza, M. Buñuales, 2015, Molecular Cancer.

Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.

J. Prieto, C. Berasain, J. Riezu-Boj, 1999, The Journal of general virology.

Induction of cytotoxic T‐cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

J. Prieto, G. Wilkinson, B. Clarke, 1997, Hepatology.

IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes.

J. Prieto, F. Rotellar, G. González-Aseguinolaza, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Prognostic model for early acute rejection after liver transplantation

J. Prieto, B. Sangro, J. Quiroga, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

In vivo and in vitro effects of arachidonic acid products on liver cell integrity following carbon tetrachloride poisoning.

F. Guarner, J. Prieto, J. Quiroga, 1983, Advances in prostaglandin, thromboxane, and leukotriene research.

Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables.

J. Prieto, J. Riezu-Boj, M. Civeira, 1993, Gut.

Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins

J. Prieto, J. Lasarte, P. Sarobe, 2002, Journal of Virology.

pretreatment variables . C to interferon alfa : a statistical analysis of Prediction of the response of chronic hepatitis

J. Prieto, J. Riezu-Boj, M. Civeira, 2006 .

Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies

J. Prieto, C. Fernández-Rodríguez, E. Larrea, 2005, Gut.

[New therapies for hepatitis C].

J. Prieto, P. Sarobe, L. Gil-Guerrero, 2006, Medicina clinica.

Acute Intermittent Porphyria: Novel Etiologic and Pathogenic Therapies Based on RNA Transfer to the Liver

J. Prieto, G. González-Aseguinolaza, J. Prieto, 2019, Hepatology.

Effect of Adenovirus-Mediated RNA Interference on Endogenous MicroRNAs in a Mouse Model of Multidrug Resistance Protein 2 Gene Silencing

O. Aparicio, J. Prieto, N. Razquin, 2006, Journal of Virology.

Splicing regulator SLU7 is essential for maintaining liver homeostasis.

R. Urtasun, J. Prieto, M. Ávila, 2014, The Journal of clinical investigation.

The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer

J. Prieto, M. Ávila, C. Berasain, 2009, Experimental biology and medicine.

X-box Binding Protein 1 Regulates Unfolded Protein, Acute-Phase, and DNA Damage Responses During Regeneration of Mouse Liver.

J. Prieto, B. Amati, M. Ávila, 2017, Gastroenterology.

Immunological landscape and immunotherapy of hepatocellular carcinoma

J. Prieto, B. Sangro, I. Melero, 2015, Nature Reviews Gastroenterology &Hepatology.

MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.

Limei Liu, Yanmin Xu, Juanjuan Shan, 2016, Cancer research.

Interleukin-12 inhibits liver-specific drug-inducible systems in vivo

J. Rivas, J. Prieto, S. Kochanek, 2008, Gene Therapy.

Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.

Juanjuan Shan, J. Prieto, C. Qian, 2009, Cancer research.

Hepatic differentiation of mouse iPS cells and analysis of liver engraftment potential of multistage iPS progeny

J. Prieto, R. Aldabe, L. Guembe, 2013, Journal of Physiology and Biochemistry.

Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I.

J. Prieto, J. Quiroga, M. Ávila, 2002, The international journal of biochemistry & cell biology.

Inflammation and Liver Cancer

J. Prieto, M. Ávila, C. Berasain, 2009, Annals of the New York Academy of Sciences.

Recombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and Patients.

J. Prieto, H. Petry, Valérie Ferreira, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells

J. Prieto, J. Lasarte, J. Esteban, 2011, Hepatology.

Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.

J. Prieto, J. Lasarte, J. Esteban, 2007, Antiviral research.

The Extra Domain A from Fibronectin Targets Antigens to TLR4-Expressing Cells and Induces Cytotoxic T Cell Responses In Vivo1

J. Prieto, C. Leclerc, S. Hervás-Stubbs, 2007, The Journal of Immunology.

Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects

J. Prieto, J. Lasarte, A. Zabaleta, 2007, Cancer Immunology, Immunotherapy.

Long-term metabolic correction of Wilson's disease in a murine model by gene therapy.

J. Prieto, F. Corrales, Í. Navarro-Blasco, 2016, Journal of hepatology.

Development of Endothelial-Specific Single Inducible Lentiviral Vectors for Genetic Engineering of Endothelial Progenitor Cells

J. Prieto, M. Kawa, M. Kramer, 2015, Scientific Reports.

Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

R. Urtasun, J. Prieto, M. Ávila, 2014, Hepatic oncology.

Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats.

J. Prieto, J. Quiroga, I. Castilla-Cortázar, 2001, Biochimica et biophysica acta.

Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I.

J. Prieto, J. Quiroga, I. Castilla-Cortázar, 2000, American journal of physiology. Gastrointestinal and liver physiology.

Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I.

J. Prieto, M. Núñez, J. Quiroga, 1997, Gastroenterology.

Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications.

R. Urtasun, J. Prieto, M. Ávila, 2017, Biochimica et biophysica acta. Molecular basis of disease.

An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells

J. Prieto, C. Qian, F. Farinati, 2005, Journal of Molecular Medicine.

HNF1alpha upregulates the human AE2 anion exchanger gene (SLC4A2) from an alternate promoter.

J. Prieto, R. Malumbres, J. Medina, 2003, Biochemical and biophysical research communications.

Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice

J. Prieto, C. Qian, S. Kochanek, 2006, Hepatology.

Potentiation of therapeutic immune responses against malignancies with monoclonal antibodies.

J. Prieto, I. Melero, I. Tirapu, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Factors influencing the production of recombinant SV40 vectors.

J. Prieto, D. Strayer, P. Fortes, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Gene therapy for liver cancer: clinical experience and future prospects.

J. Prieto, B. Sangro, J. Prieto, 2010, Current opinion in molecular therapeutics.

Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients.

J. Barrio, N. Satyamurthy, M. Phelps, 2005, Gastroenterology.

Tracing transgene expression in cancer gene therapy: a requirement for rational progress in the field.

Cheng Qian, Jesús Prieto, Bruno Sangro, 2002, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

M Transition Genes − 2 Suppressing G Hepatocellular Carcinoma Sustains Malignant Character by Overexpression of the Transcription Factor MEF 2 D in

Leina Ma, Jia Liu, Limei Liu, 2014 .

Regulation of Amphiregulin Gene Expression by β-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System

Raquel Urtasun, Jesús Prieto, Monica Santamaria, 2012, PloS one.

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome

J. Prieto, L. Rodrigo, C. López-Larrea, 2014, PloS one.

Peptide inhibitors of transforming growth factor‐β enhance the efficacy of antitumor immunotherapy

J. Prieto, P. Berraondo, J. Lasarte, 2009, International journal of cancer.

[The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].

J. Prieto, I. Melero, J. Pérez-Gracia, 2006, Anales del sistema sanitario de Navarra.

New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system

J. Prieto, M. Ávila, C. Berasain, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.

David C. Lee, J. Prieto, M. Ávila, 2006, Cancer research.

Liver damage using suicide genes. A model for oval cell activation.

J. Prieto, C. Qian, B. Sangro, 2000, The American journal of pathology.

ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia.

J. Prieto, J. Marin, C. Berasain, 2017, Journal of hepatology.

GAMMA-INTERFERON AND CHRONIC FATIGUE SYNDROME

J. Prieto, M. Civeira, A. Castilla, 1988, The Lancet.

Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancer.

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2011, Molecular Therapy.

Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters.

J. Prieto, G. González-Aseguinolaza, M. Buñuales, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNγ-induced apoptosis

J. Prieto, C. Qian, I. Melero, 2003, Gene Therapy.

Lethality in an anti‐angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1

J. Prieto, C. Qian, S. Kochanek, 2008, The journal of gene medicine.

Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model

T. Sauerbruch, J. Prieto, C. Qian, 2005, Hepatology.

Biologic therapy of liver tumors.

J. Prieto, C. Qian, B. Sangro, 2004, The Surgical clinics of North America.

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C.

J. Prieto, B. Sangro, I. Melero, 2013, Journal of hepatology.

[Eosinophilic pulmonary disease caused by Fasciola hepatica. Description of a case and review of the literature].

J. Prieto, J. Quiroga, L. Aliaga, 1984, Medicina clinica.

Nuclear α1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells.

J. Prieto, C. Qian, M. Ávila, 2013, Gastroenterology.

Partial splenic embolization in the treatment of thrombocytopenia after liver transplantation.

J. Prieto, B. Sangro, J. Quiroga, 1997, Transplantation.

A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury.

J. Prieto, P. Greenwel, I. Castilla-Cortázar, 2003, Cytokine.

Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis

J. Prieto, P. Fortes, M. Zaratiegui, 2007, Gene Therapy.

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer

R. Urtasun, J. Prieto, M. Ávila, 2011, Cancers.

Genetics in liver diseases.

B. Bacon, J. Prieto, R. O. Oude Elferink, 2007, Journal of hepatology.

Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis.

J. Prieto, B. Sangro, J. Bilbao, 1992, European journal of radiology.

Degree and distribution of variability in the 5' untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV)

J. Prieto, M. García-Delgado, F. J. Novo, 1998, Journal of viral hepatitis.

Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients.

C. Frost, P. Simmonds, M. Colombo, 1996, Journal of hepatology.

In vivo cytotoxic T-lymphocyte induction may take place via CD8 T helper lymphocytes.

J. Prieto, J. Lasarte, P. Sarobe, 1995, Research in immunology.

Herpes zoster after liver transplantation: Incidence, risk factors, and complications

J. Prieto, B. Sangro, J. Quiroga, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB

Kris Gevaert, Petra Van Damme, Jesus Prieto, 2012, Proceedings of the National Academy of Sciences.

Simple strategy to induce antibodies of distinct specificity: Application to the mapping of gp120 and inhibition of HIV‐1 infectivity

J. Prieto, C. Berasain, S. Hervás-Stubbs, 1995, European journal of immunology.

Autophagic response in the Rabbit Hemorrhagic Disease, an animal model of virally-induced fulminant hepatic failure

J. Prieto, J. González‐Gallego, B. San-Miguel, 2014, Veterinary Research.

IL12-Mediated Liver Inflammation Reduces the Formation of AAV Transcriptionally Active Forms but Has No Effect over Preexisting AAV Transgene Expression

J. Prieto, G. González-Aseguinolaza, Á. Vales, 2013, PloS one.

Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularis.

J. Prieto, G. González-Aseguinolaza, J. Bilbao, 2017, Human gene therapy. Clinical development.

Adeno-associated virus liver transduction efficiency measured by in vivo [18F]FHBG positron emission tomography imaging in rodents and nonhuman primates.

J. Lanciego, J. Prieto, H. Petry, 2011, Human gene therapy.

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment.

J. Prieto, J. Lasarte, M. Civeira, 1996, Journal of hepatology.

Improved dendritic cell‐based immunization against hepatitis C virus using peptide inhibitors of interleukin 10

J. Pawlotsky, J. Prieto, J. Lasarte, 2011, Hepatology.

Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences.

Jesús Prieto, J. Prieto, M. Ávila, 2010, World journal of gastroenterology.

Characterization of the human Nα-terminal acetyltransferase B enzymatic complex

J. Prieto, E. Larrea, R. Aldabe, 2009, BMC proceedings.

Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis

E. Salido, J. Prieto, G. González-Aseguinolaza, 2016, The Journal of Immunology.

Graft-versus-host disease after liver transplantation.

J. Prieto, J. Quiroga, J. Herrero, 1993, Journal of the American Academy of Dermatology.

Prognostic factors and prevention of radioembolization‐induced liver disease

J. Prieto, B. Sangro, J. Quiroga, 2013, Hepatology.

Transarterial therapies for hepatocellular carcinoma.

J. Prieto, B. Sangro, D. D’Avola, 2011, Expert opinion on pharmacotherapy.

Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.

J. Prieto, B. Sangro, J. Quiroga, 2006, International journal of radiation oncology, biology, physics.

Amphiregulin: a new growth factor in hepatocarcinogenesis.

J. Prieto, M. Ávila, C. Berasain, 2007, Cancer letters.

Activation of the Transcription Factor GLI1 by WNT Signaling Underlies the Role of SULFATASE 2 as a Regulator of Tissue Regeneration*

E. Hanse, Jing-jing Han, S. Sanderson, 2013, The Journal of Biological Chemistry.

The woodchuck interferon‐α system: Cloning, family description, and biologic activity

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2002 .

Targeting Interferon‐α to the Liver: Apolipoprotein A‐I as a Scaffold for Protein Delivery

J. Prieto, P. Berraondo, J. Fioravanti, 2013 .

Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer.

J. Prieto, C. Qian, S. Kochanek, 2004, Gastroenterology.

AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers

J. Prieto, M. Enguita, N. Razquin, 2011, Gene Therapy.

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C

J. Prieto, J. Lasarte, M. Civeira, 1998, Hepatology.

Gene therapy of liver cancer: an update

J. Prieto, G. González-Aseguinolaza, R. Hernández-Alcoceba, 2011 .

Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.

J. Prieto, I. Melero, G. González-Aseguinolaza, 2010, Journal of hepatology.

A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice

J. Prieto, J. Lasarte, J. Riezu-Boj, 2010, The Journal of Immunology.

Harnessing High Density Lipoproteins to Block Transforming Growth Factor Beta and to Inhibit the Growth of Liver Tumor Metastases

J. Prieto, P. Berraondo, V. Umansky, 2014, PloS one.

Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice.

M. Alegre, J. Artieda, J. Prieto, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Transcriptomic effects of Tet-on and mifepristone-inducible systems in mouse liver.

J. Prieto, C. Smerdou, J. de Las Rivas, 2008, Human gene therapy.

Liver Expression of a MiniATP7B Gene Results in Long‐Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice

J. Prieto, B. Bénichou, M. Arruebo, 2019, Hepatology.

Oxidation of specific methionine and tryptophan residues of apolipoprotein A‐I in hepatocarcinogenesis

Shelly C. Lu, J. Prieto, F. Corrales, 2005, Proteomics.

Advances in interleukin-12 gene therapy for acquired liver diseases.

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2009, Current gene therapy.

Implication of human N-α-acetyltransferase 5 in cellular proliferation and carcinogenesis

J. Prieto, E. Larrea, R. Aldabe, 2008, Oncogene.

Primary biliary cholangitis: pathogenic mechanisms

J. Prieto, J. Banales, J. Medina, 2020, Current opinion in gastroenterology.

Malignancies with Monoclonal Antibodies Potentiation of Therapeutic Immune Responses against Updated

J. Prieto, I. Melero, I. Tirapu, 2003 .

T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides.

J. Prieto, J. Lasarte, P. Sarobe, 1999, International immunology.

Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms

J. Martinez-Climent, J. Prieto, O. Rabal, 2017, Haematologica.

Anion exchanger 2 is critical for CD8+ T cells to maintain pHi homeostasis and modulate immune responses

J. Prieto, S. Hervás-Stubbs, J. Banales, 2014, European journal of immunology.

Induction of cytotoxic T lymphocytes in mice against the principal neutralizing domain of HIV-1 by immunization with an engineered T-cytotoxic-T-helper synthetic peptide construct.

J. Prieto, J. Lasarte, P. Sarobe, 1992, Cellular immunology.

Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells

E. Andreu, F. Prósper, J. Prieto, 2017, Translational research : the journal of laboratory and clinical medicine.

Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury

D. Brenner, J. Prieto, J. Fagin, 2004, Gut.

IL-12 gene therapy for cancer: in synergy with other immunotherapies.

Lieping Chen, J. Prieto, C. Qian, 2001, Trends in immunology.

TMEM173 Alternative Spliced Isoforms Modulate Viral Replication through the STING Pathway

J. Prieto, P. Fortes, C. Lloréns, 2018, ImmunoHorizons.

Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression

R. Urtasun, S. Vicent, J. Prieto, 2016, Oncogene.

Optimization of the Tet-on system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors.

J. Prieto, C. Qian, W. Hillen, 2003, Cancer research.

Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives

J. Prieto, B. Sangro, G. González-Aseguinolaza, 2013, Expert opinion on investigational drugs.

Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.

J. Prieto, N. Van Rooijen, G. González-Aseguinolaza, 2005, Vaccine.

Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells.

J. Prieto, I. Melero, N. Razquin, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitment.

J. Prieto, C. Qian, I. Melero, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination 1

J. Prieto, I. Melero, J. Lasarte, 2003, The Journal of Immunology.

Identification of HLA‐B27–restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen

J. Prieto, G. Brem, E. Huarte, 2002, International journal of cancer.

Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor

J. Prieto, O. Rabal, J. Oyarzábal, 2017, Oncotarget.

Phase I dose escalation study of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis.

J. Prieto, B. Sangro, T. Crocenzi, 2013 .

Immunization with a tumor‐associated CTL epitope plus a tumor‐related or unrelated Th1 helper peptide elicits protective CTL immunity

J. Prieto, I. Melero, J. Lasarte, 2001, European journal of immunology.

Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas.

J. Prieto, C. Smerdou, J. R. Rodríguez-Madoz, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma.

Shelly C. Lu, J. Prieto, F. Corrales, 2000, Journal of hepatology.

CD8 T Cell Priming in the Presence of IFN-α Renders CTLs with Improved Responsiveness to Homeostatic Cytokines and Recall Antigens: Important Traits for Adoptive T Cell Therapy

H. Pircher, J. Prieto, I. Melero, 2012, The Journal of Immunology.

A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell Responses In Vivo

J. Prieto, J. Lasarte, P. Sarobe, 2013, BioMed research international.

Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses.

J. Prieto, J. Lasarte, P. Sarobe, 2003, International immunology.

Evaluation of bioluminescent imaging for noninvasive monitoring of colorectal cancer progression in the liver and its response to immunogene therapy

C. Ortiz de Solórzano, J. Prieto, G. González-Aseguinolaza, 2009, Molecular Cancer.

Therapy of cancer by cytokines mediated by gene therapy approach

J. Prieto, C. Qian, Xin Yuan Liu, 2006, Cell Research.

J. Prieto, B. Sangro, G. Frühbeck, 2015, European journal of gastroenterology & hepatology.

Induction of Multiepitopic and Long‐Lasting Immune Responses Against Tumour Antigens by Immunization with Peptides, DNA and Recombinant Adenoviruses Expressing Minigenes

J. Prieto, E. Huarte, J. Lasarte, 2009, Scandinavian journal of immunology.

Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer.

J. Prieto, P. Berraondo, J. Lasarte, 2007, Journal of hepatology.

Deficient display of CD3 on lymphocytes of patients with chronic fatigue syndrome.

J. Prieto, M. Civeira, M. Subirá, 1989, The Journal of infectious diseases.

Regresión tumoral espontánea. A propósito de dos casos

J. Prieto, B. Sangro, M. Sureda, 1990 .

Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell death.

J. Prieto, C. Qian, I. Melero, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Activation-induced T-Cell Death Intratumor Gene Transfer of Interleukin-12 Inhibiting Anti-ICAM-2 Monoclonal Antibody Synergizes with

J. Prieto, C. Qian, I. Melero, 2003 .

Immunity Elicited by Peptide Vaccination Activity, as well as Long-Lasting Tumor -Dependent Antiangiogenic g with IFN-T Cells + Activation of Tumor-Primed CD4 Regulatory Cells Inhibit + /CD25+ CD4

J. Prieto, J. Lasarte, Dotor, 2003 .

Reply:

J. Prieto, F. Corrales, J. Medina, 2010 .

HSV-1 Cgal+ Infection Promotes Quaking RNA Binding Protein Production and Induces Nuclear-Cytoplasmic Shuttling of Quaking I-5 Isoform in Human Hepatoma Cells*

J. Prieto, A. Epstein, M. I. Mora, 2011, Molecular & Cellular Proteomics.

Tissue-specific N-terminal isoforms from overlapping alternate promoters of the human AE2 anion exchanger gene.

J. Prieto, J. Medina, J. Lecanda, 2000, Biochemical and biophysical research communications.

Adoptive T Cell Therapy and Recall Antigens: Important Traits for Responsiveness to Homeostatic Cytokines Renders CTLs with Improved a CD8 T Cell Priming in the Presence of IFN-Ignacio

H. Pircher, J. Prieto, I. Melero, 2012 .

In situ localization of anion exchanger-2 in the human kidney

J. Prieto, E. de Álava, R. Malumbres, 2000, Cell and Tissue Research.

Inefficient chronic activation of parietal cells in Ae2a,b(-/-) mice.

J. Prieto, R. P. Elferink, F. Muruzábal, 2006, The American journal of pathology.

PET imaging of thymidine kinase gene expression in the liver of non-human primates following systemic delivery of an adenoviral vector

J. Prieto, I. Melero, S. Hervás-Stubbs, 2009, Gene Therapy.

Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure

J. Prieto, B. Sangro, F. Perez-Vizcaino, 2013, PloS one.

In situ detection of AE2 anion-exchanger mRNA in the human liver

J. Prieto, L. Montuenga, J. Medina, 1998, Cell and Tissue Research.

Molecular cloning and characterization of the human AE2 anion exchanger (SLC4A2) gene.

J. Prieto, J. Medina, A. Acín, 2017, Genomics.

Transjugular intrahepatic portocaval shunt after thrombus disruption in partially thrombosed portal veins

H. Rousseau, J. Prieto, J. Bilbao, 1994, Cardiovascular and Interventional Radiology.

Transjugular intrahepatic portosystemic shunts using the Wallstent prosthesis: A follow-up study

H. Rousseau, J. Prieto, J. Vinel, 2004, CardioVascular and Interventional Radiology.

Transjugular intrahepatic portosystemic shunt: evaluation with Doppler sonography.

H. Rousseau, J. Prieto, J. Vinel, 1993, Radiology.

A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system

J. Prieto, E. Larrea, C. Smerdou, 2014, Cellular and Molecular Life Sciences.

Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseases

N. LaRusso, J. Prieto, T. Masyuk, 2014, Gut.

A novel system for the production of high levels of functional human therapeutic proteins in stable cells with a Semliki Forest virus noncytopathic vector.

J. Prieto, C. Smerdou, Marta Ruiz-Guillen, 2010, New biotechnology.

Development of a new noncytopathic Semliki Forest virus vector providing high expression levels and stability.

J. Prieto, N. Razquin, C. Smerdou, 2008, Virology.

Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor.

J. Prieto, C. Qian, V. Schmitz, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Inflammation, HCC and sex: IL-6 in the centre of the triangle.

J. Prieto, J. Prieto, 2008, Journal of hepatology.

Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant.

J. Prieto, J. Muntané, M. L. de la Mata, 2013, The Journal of surgical research.

The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.

J. Prieto, M. Ávila, C. Berasain, 2009, Journal of hepatology.

Gene transfer to liver cancer cells of B7-1 plus interleukin 12 changes immunoeffector mechanisms and suppresses helper T cell type 1 cytokine production induced by interleukin 12 alone.

J. Prieto, C. Qian, Y. Sun, 2000, Human gene therapy.

Role of cardiotrophin‐1 in the regulation of metabolic circadian rhythms and adipose core clock genes in mice and characterization of 24‐h circulating CT‐1 profiles in normal‐weight and overweight/obese subjects

M. Moreno-Aliaga, J. Martínez, J. Prieto, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institution.

I. Bilbao, J. Prieto, B. Sangro, 1998, Surgery.

Case Report: Effectiveness of Lamivudine in Treatment of Acute Recurrent Hepatitis B After Liver Transplantation

J. Prieto, B. Sangro, J. Quiroga, 1998, Digestive Diseases and Sciences.

Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.

J. Prieto, B. Sangro, J. Quiroga, 1998, Digestive diseases and sciences.

Adenovirus‐mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma

J. Prieto, C. Qian, V. Schmitz, 2001, Hepatology.

IFN-α5 Mediates Stronger Tyk2-Stat-Dependent Activation and Higher Expression of 2′,5′-Oligoadenylate Synthetase Than IFN-α2 in Liver Cells

J. Prieto, E. Larrea, J. Riezu-Boj, 2004 .

Proteomic analysis of human hepatoma cells expressing methionine adenosyltransferase I/III: Characterization of DDX3X as a target of S-adenosylmethionine.

Shelly C. Lu, J. Prieto, F. Corrales, 2012, Journal of proteomics.

Chloride/bicarbonate exchange in PBC: A clue for pathogenesis?

J. Prieto, J. Medina, J. Prieto, 1998 .

Abnormal expression of anion exchanger genes in primary biliary cirrhosis.

J. Prieto, N. García, J. Medina, 1993, Gastroenterology.

Taurocholate-stimulated leukotriene C4 biosynthesis and leukotriene C4-stimulated choleresis in isolated rat liver.

J. Prieto, C. Qian, J. Quiroga, 1995, Gastroenterology.

Targeted Expression of Human Serum Albumin to Potato Tubers

J. Prieto, J. Sánchez-Serrano, Á. Mingo-Castel, 2002, Transgenic Research.

479. Development and Characterization of a New Noncytopathic Vector Derived from Semliki Forest Virus

J. Prieto, N. Razquin, C. Smerdou, 2006 .

Chronic exposure to IFNα drives medullar lymphopoiesis towards T-cell differentiation in mice

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2015, Haematologica.

The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis

J. Prieto, S. Lotersztajn, M. Ávila, 2008, Hepatology.

Determination of 2,3-dinor-6-ketoprostaglandin F1 alpha in urine samples by liquid chromatography and radioimmunoassay.

F. Guarner, J. Prieto, J. Quiroga, 1986, Journal of chromatography.

Thrombopenic purpura induced by a monoclonal antibody directed to a 35-kilodalton surface protein (p35) expressed on murine platelets and endothelial cells.

J. Prieto, I. Melero, G. Mazzolini, 2001, Experimental hematology.

Intracerebroventricular infusion of sodium chloride-rich artificial cerebrospinal fluid in rats induces natriuresis and releases an inhibitor of prostaglandin synthesis.

F. Guarner, J. Prieto, J. Quiroga, 1984, Clinical science.

Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C‐X‐C chemokine receptor 4 axis

R. Urtasun, S. Morini, J. Prieto, 2015, Hepatology.

Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice.

J. Prieto, M. Ávila, C. Berasain, 2012, Journal of hepatology.

Lack of Abcc 3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice

J. Prieto, J. Marin, M. Ávila, 2011 .

Characterization of woodchuck apolipoprotein A‐I: A new tool for drug delivery and identification of altered isoforms in the woodchuck chronic hepatitis model

J. Prieto, G. González-Aseguinolaza, P. Berraondo, 2011, Journal of medical virology.

Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report

J. Prieto, B. Sangro, J. Quiroga, 2009, Clinical transplantation.

Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.

J. Prieto, B. Sangro, M. Ávila, 2009, Cancer research.

Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of PD-L1 in Hepatocellular Carcinoma Cells.

Limei Liu, Juanjuan Shan, Junjie Shen, 2020, Gastroenterology.

Encymatic release of angiostatin like molecule and characterization of its angiostatic and antitumoral effects

J. Prieto, V. Schmitz, M. Barajas, 2002 .

Short-term intratumoral interleukin-12 expressed from an alphaviral vector is sufficient to induce an efficient antitumoral response against spontaneous hepatocellular carcinomas.

J. Prieto, M. Zabala, C. Smerdou, 2014, Human gene therapy.

Efficacy and Toxicity of Intra-Arterial Cisplatin and Etoposide for Advanced Hepatocellular Carcinoma

J. Prieto, B. Sangro, J. Quiroga, 2002, Oncology.

Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2−/− Mice

R. Urtasun, J. Prieto, F. Corrales, 2010, PloS one.

Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C.

J. Prieto, M. Martínez-González, J. Lasarte, 1997, Gastroenterology.

Idiopathic adulthood ductopenia: long-term follow-up after liver transplantation.

J. Prieto, B. Sangro, J. Quiroga, 2001, Digestive Diseases and Sciences.

Hepatitis C virus envelope components alter localization of hepatocyte tight junction–associated proteins and promote occludin retention in the endoplasmic reticulum

O. Barreiro, J. Prieto, R. Aldabe, 2008, Hepatology.

Identification of Replication-competent HSV-1 Cgal+ Strain Signaling Targets in Human Hepatoma Cells by Functional Organelle Proteomics*S

J. Prieto, A. Epstein, M. I. Mora, 2009, Molecular & Cellular Proteomics.

Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters.

J. Prieto, C. Qian, M. Buñuales, 2007, Human gene therapy.

A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling

J. Prieto, G. González-Aseguinolaza, M. Buñuales, 2016, PloS one.

A RIG-I 2CARD-MAVS200 Chimeric Protein Reconstitutes IFN-β Induction and Antiviral Response in Models Deficient in Type I IFN Response

J. Prieto, A. García-Sastre, Irene Crespo, 2015, Journal of Innate Immunity.

HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway.

J. Prieto, E. Larrea, R. Aldabe, 2007, Antiviral research.

Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-κB nuclear translocation

J. Prieto, C. Berasain, E. Larrea, 2005 .

Cytoprotective effect of prostaglandins on isolated rat liver cells.

F. Guarner, J. Prieto, M. Fremont-Smith, 2008, Liver.

Epidermal Growth Factor Receptor Signaling in Hepatocellular Carcinoma: Inflammatory Activation and a New Intracellular Regulatory Mechanism

R. Urtasun, J. Prieto, F. Corrales, 2012, Digestive Diseases.

Victor Epithelial Cells Immunostimulatory Functions in Liver Effects of Type I Interferon and Activates Oncostatin M Enhances the Antiviral

J. Prieto, V. Segura, E. Larrea, 2009 .

Insulin‐like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats

J. Prieto, N. Razquin, P. Fortes, 2009, Hepatology.

Redox regulation of methylthioadenosine phosphorylase in liver cells: molecular mechanism and functional implications.

J. Prieto, F. Corrales, M. Ávila, 2008, Biochemical Journal.

Amphiregulin induces the alternative splicing of p73 into its oncogenic isoform DeltaEx2p73 in human hepatocellular tumors.

J. Prieto, C. Balabaud, P. Bioulac-Sage, 2009, Gastroenterology.

Expression of Wilms' tumor suppressor in the liver with cirrhosis: Relation to hepatocyte nuclear factor 4 and hepatocellular function

J. Prieto, M. Ávila, J. Herrero, 2003, Hepatology.

Prohibitin-1 deficiency promotes inflammation and increases sensitivity to liver injury.

B. O’Malley, J. Prieto, F. Corrales, 2012, Journal of proteomics.

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria

J. Prieto, B. Sangro, J. Quiroga, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

A phase I clinical trial of intratumoral injection of adenovirus encoding interleukin-12 in patients with hepatocellular carcinoma and other advanced gastrointestinal tumors

J. Prieto, B. Sangro, J. Quiroga, 2003 .

Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma.

J. Prieto, B. Sangro, J. Quiroga, 2010, International journal of radiation oncology, biology, physics.

Hepatitis C virus (HCV) viremia in patients with hepatocellular carcinoma (HCC) detected by nested-PCR

J. Prieto, B. Sangro, J. Herrero, 1991 .

Detection of hepatitis C virus antibodies with new recombinant antigens: assessment in chronic liver diseases.

J. Prieto, J. Riezu-Boj, M. Civeira, 1992, Journal of Hepatology.

Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides.

J. Prieto, C. Berasain, J. Riezu-Boj, 1993, Journal of hepatology.

Cardiotrophin‐1 decreases intestinal sugar uptake in mice and in Caco‐2 cells

M. Moreno-Aliaga, J. Prieto, J. A. Martínez, 2016, Acta physiologica.

Protein Abundance of Hepatic Drug Transporters in Patients With Different Forms of Liver Damage

J. Prieto, S. Oswald, M. Droździk, 2019, Clinical pharmacology and therapeutics.

Increased liver stiffness values in patients with heart failure.

J. Prieto, B. Sangro, J. Quiroga, 2013, Acta gastro-enterologica Belgica.

Liver transplantation in cirrhotic patients over 60 years of age.

J. Prieto, B. Sangro, J. Quiroga, 1998, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[Comparison of the M and XL FibroScan(®) probes to estimate liver stiffness by transient elastography].

J. Prieto, B. Sangro, J. Quiroga, 2014, Gastroenterology & hepatology.

Abstract 4387: Antiviral and antitumoral effects of the anti-CTLA4 agent tremelimumab in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C virus (HCV) infection: Results from a phase II clinical trial

J. Prieto, B. Sangro, I. Melero, 2012 .

Human fibrogenesis and transforming growth factor beta-1.

J. Prieto, A. Castilla, 1993, Journal of hepatology.

Disposable sensors for rapid screening of mutated genes

J. Prieto, A. Nuñez, F. Pariente, 2010, Analytical and bioanalytical chemistry.

IFN-alpha5 mediates stronger Tyk2-stat-dependent activation and higher expression of 2',5'-oligoadenylate synthetase than IFN-alpha2 in liver cells.

J. Prieto, E. Larrea, J. Riezu-Boj, 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial (final report Maag Lever Darm Stichting projectno. WS 00???78 (WS 97/87))

J. Prieto, B. Sangro, J. Frystyk, 2006 .